Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis
- PMID: 38381656
- DOI: 10.1515/revneuro-2024-0010
Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis
Abstract
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease which damages upper and lower motor neurons (UMN and LMN) innervating the muscles of the trunk, extremities, head, neck and face in cerebrum, brain stem and spinal cord, which results in the progressive weakness, atrophy and fasciculation of muscle innervated by the related UMN and LMN, accompanying with the pathological signs leaded by the cortical spinal lateral tract lesion. The pathogenesis about ALS is not fully understood, and no specific drugs are available to cure and prevent the progression of this disease at present. In this review, we reviewed the structure and associated functions of copper-zinc superoxide dismutase 1 (SOD1), discuss why SOD1 is crucial to the pathogenesis of ALS, and outline the pathogenic mechanisms of SOD1 in ALS that have been identified at recent years, including glutamate-related excitotoxicity, mitochondrial dysfunction, endoplasmic reticulum stress, oxidative stress, axonal transport disruption, prion-like propagation, and the non-cytologic toxicity of glial cells. This review will help us to deeply understand the current progression in this field of SOD1 pathogenic mechanisms in ALS.
Keywords: amyotrophic lateral sclerosis; axonal transport disruption; endoplasmic reticulum stress; excitotoxicity; mitochondrial dysfunction; oxidative stress.
© 2024 Walter de Gruyter GmbH, Berlin/Boston.
Similar articles
-
SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.Adv Biol Regul. 2016 Jan;60:95-104. doi: 10.1016/j.jbior.2015.10.006. Epub 2015 Oct 31. Adv Biol Regul. 2016. PMID: 26563614 Review.
-
[Prion-like Properties of Misfolded Cu/Zn-superoxide Dismutase in Amyotrophic Lateral Sclerosis: Update and Perspectives].Yakugaku Zasshi. 2019;139(7):1015-1019. doi: 10.1248/yakushi.18-00165-5. Yakugaku Zasshi. 2019. PMID: 31257248 Review. Japanese.
-
A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt A):2119-2130. doi: 10.1016/j.bbadis.2018.03.015. Epub 2018 Mar 16. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 29551730
-
IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW.Brain Res Bull. 2020 Jun;159:32-43. doi: 10.1016/j.brainresbull.2020.03.012. Epub 2020 Apr 2. Brain Res Bull. 2020. PMID: 32247802 Review.
-
Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?Transl Neurodegener. 2020 Aug 19;9(1):33. doi: 10.1186/s40035-020-00209-y. Transl Neurodegener. 2020. PMID: 32811540 Free PMC article. Review.
Cited by
-
Oxidative Stress-mediated Lipid Peroxidation-derived Lipid Aldehydes in the Pathophysiology of Neurodegenerative Diseases.Curr Neuropharmacol. 2025;23(6):671-685. doi: 10.2174/011570159X342720241014164650. Curr Neuropharmacol. 2025. PMID: 39440770 Free PMC article. Review.
-
Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications.Front Mol Biosci. 2025 Jun 30;12:1608853. doi: 10.3389/fmolb.2025.1608853. eCollection 2025. Front Mol Biosci. 2025. PMID: 40661315 Free PMC article. Review.
-
Oxidative Stress and Age-Related Tumors.Antioxidants (Basel). 2024 Sep 13;13(9):1109. doi: 10.3390/antiox13091109. Antioxidants (Basel). 2024. PMID: 39334768 Free PMC article. Review.
-
Potential common pathogenesis of several neurodegenerative diseases.Neural Regen Res. 2026 Mar 1;21(3):972-988. doi: 10.4103/NRR.NRR-D-24-01054. Epub 2025 May 30. Neural Regen Res. 2026. PMID: 40522761 Free PMC article.
-
Role of micronutrition in patients with oral cancer and nutritional intervention strategies.Front Nutr. 2025 Jul 24;12:1616344. doi: 10.3389/fnut.2025.1616344. eCollection 2025. Front Nutr. 2025. PMID: 40777177 Free PMC article. Review.
References
-
- Alqallaf, A., Cates, D.W., Render, K.P., and Patel, K.A. (2024). Sodium phenylbutyrate and taurursodiol: a new therapeutic option for the treatment of amyotrophic lateral sclerosis. Ann. Pharmacother. 58: 165–173, https://doi.org/10.1177/10600280231172802 . - DOI
-
- Arredondo, C., Cefaliello, C., Dyrda, A., Jury, N., Martinez, P., Díaz, I., Amaro, A., Tran, H., Morales, D., Pertusa, M., et al.. (2022). Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons. Neuron 110: 1656–1670.e12, https://doi.org/10.1016/j.neuron.2022.02.010 . - DOI
-
- Ayers, J.I., Xu, G., Dillon, K., Lu, Q., Chen, Z., Beckman, J., Moreno-Romero, A.K., Zamora, D.L., Galaleldeen, A., and Borchelt, D.R. (2021). Variation in the vulnerability of mice expressing human superoxide dismutase 1 to prion-like seeding: a study of the influence of primary amino acid sequence. Acta. Neuropathol. Commun. 9: 92, https://doi.org/10.1186/s40478-021-01191-w . - DOI
-
- Bald, E.M., Nance, C.S., and Schultz, J.L. (2021). Melatonin may slow disease progression in amyotrophic lateral sclerosis: findings from the pooled resource open-access ALS clinic trials database. Muscle Nerve 63: 572–576, https://doi.org/10.1002/mus.27168 . - DOI
-
- Bär, P.R. (2000). Motor neuron disease in vitro: the use of cultured motor neurons to study amyotrophic lateral sclerosis. Eur. J. Pharmacol. 405: 285–295, https://doi.org/10.1016/s0014-2999(00)00560-4 . - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous